Droxidopa News
Most Popular Droxidopa Story
In a stunner, Chelsea's hypotension drug flunks Phase III
Chelsea Therapeutics stunned analysts and investors this morning, reporting that a late-stage trial of its experimental neurological disorder drug Droxidopa failed to hit its primary endpoint. The Read more...
Latest Headlines
- September 20, 2010
- November 3, 2009
- September 24, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
